About Biocentra

Discover our story, our mission, and the people driving innovation in pharmaceutical science.

Our Mission

To discover, develop, and deliver innovative therapies that address the world's most challenging diseases, improving patient outcomes and advancing the standard of care across therapeutic areas.

Our Vision

To be a globally recognized leader in pharmaceutical innovation, transforming scientific breakthroughs into accessible treatments that enhance and extend human life.

Our History

From a small research lab to a global pharmaceutical company — our journey of discovery.

2009

Biocentra Founded

Founded in New York City by Dr. Sarah Mitchell and Dr. James Callahan with a vision to revolutionize targeted cancer therapies.

2013

First Research Facility

Opened our flagship research center in Bridgewater, New Jersey, expanding capabilities in molecular biology and drug discovery.

2016

First FDA Approval

Received FDA approval for BCT-101, our first oncology therapy targeting HER2-positive breast cancer, marking a major milestone.

2019

International Expansion

Expanded operations to Europe and Asia, establishing partnerships with leading research institutions and distribution networks.

2022

Pipeline Milestone

Achieved 40+ active compounds in pipeline across oncology, cardiovascular, neurology, and rare diseases. Third FDA approval received.

2025

Innovation Center Launch

Opened a 120,000 sq ft innovation center in New Jersey and announced development of next-generation gene therapies.

Leadership Team

Meet the experts guiding Biocentra's vision and scientific excellence.

SM

Dr. Sarah Mitchell

Chief Executive Officer

Over 25 years of pharmaceutical leadership. Previously CEO of MedCore Therapeutics and SVP at Pfizer. PhD in Biochemistry from MIT.

JC

Dr. James Callahan

Chief Scientific Officer

Co-founder and leading researcher in oncology drug development. Former Harvard Medical School professor with 200+ peer-reviewed publications.

DR

David Richardson

Chief Financial Officer

Seasoned financial executive with 20 years in life sciences. Previously CFO at BioVentures Group and Senior Director at Goldman Sachs Healthcare.

PW

Dr. Patricia Wu

Chief Medical Officer

Board-certified neurologist and former FDA review division director. Leads clinical development strategy and regulatory affairs.

Our Facilities

State-of-the-art facilities designed for scientific excellence and manufacturing precision.

New York Headquarters

350 Fifth Avenue, Suite 4200, New York, NY 10118. Our global headquarters houses executive leadership, corporate operations, and business development teams.

New Jersey Research Center

120,000 sq ft innovation center in Bridgewater, NJ. Houses 400+ scientists working across drug discovery, preclinical development, and clinical research.

Texas Distribution Hub

250,000 sq ft distribution and logistics center in Dallas, TX. Manages global supply chain and cold-chain storage for temperature-sensitive therapies.

Our Values

The principles that guide every decision we make.

Integrity

We uphold the highest ethical standards in all our operations, research, and business relationships.

Innovation

We push the boundaries of science to discover novel solutions for unmet medical needs.

Patient Safety

Patient well-being is at the heart of every decision we make, from research to delivery.

Quality

We maintain rigorous quality standards across all processes, ensuring reliable and effective therapies.

Collaboration

We partner with leading institutions and researchers to accelerate scientific discovery and impact.

Transparency

We communicate openly with stakeholders, regulators, and the communities we serve.